Generic antiepileptic drug prescribing: A cross-sectional study

Jennifer Meyer, David Fardo, Steven T. Fleming, Claudia Hopenhayn, Yevgeniya Gokun, Melody Ryan

Research output: Contribution to journalArticlepeer-review

9 Scopus citations


The use of generic antiepileptic drugs (AEDs) in patients with epilepsy is controversial. The purpose of this study is to identify patient characteristics associated with increased odds of receiving a generic AED product. A large commercial database was used to identify patients with a primary diagnosis of epilepsy who were prescribed an AED during a three-month window. Data analysis found that those ≥ 65. years old had 15.7% greater odds of receiving a generic AED (OR = 1.157; 95% CI = 1.056-1.268). Patients with Medicaid were found to have 2.44 times the odds of having had a generic AED prescription (OR = 2.44; CI = 2.168-2.754). Patients residing in the Northeast had 12.6% decreased odds of receiving a generic AED (OR = 0.874; CI = 0.821-0.931). These patient characteristics could signify certain health care disparities and may represent potential confounders to future observational studies.

Original languageEnglish
Pages (from-to)1-6
Number of pages6
JournalEpilepsy and Behavior
Issue number1
StatePublished - Jan 2013

Bibliographical note

Funding Information:
The project described was supported by the National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health through Grant UL1RR033173 . The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.


  • Antiepileptic drugs
  • Cross-sectional
  • Epilepsy
  • Generic drugs
  • Prescribing

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology
  • Behavioral Neuroscience


Dive into the research topics of 'Generic antiepileptic drug prescribing: A cross-sectional study'. Together they form a unique fingerprint.

Cite this